In this era of a pandemic, why do we need the placebo controls for regulatory agency or Food and Drug Administration (FDA)-approved clinical trials aimed at COVID-19 patients? The answer is always that we have to establish a ruler with a baseline onto which efficacy measurements can be statistically judged.<a href="https://doi.org/10.1007/s00005-021-00612-x">https://doi.org/10.1007/s00005-021-00612-x</a> - 2021

In this era of a pandemic, why do we need the placebo controls for regulatory agency or Food and Drug Administration (FDA)-approved clinical trials aimed at COVID-19 patients? The answer is always that we have to establish a ruler with a baseline onto which efficacy measurements can be statistically judged. https://doi.org/10.1007/s00005-021-00612-x - 2021

In this era of a pandemic, why do we need the placebo controls for regulatory agency or Food and Drug Administration (FDA)-approved clinical trials aimed at COVID-19 patients? The answer is always that we have to establish a ruler with a baseline onto which efficacy measurements can be statistically judged.<a href="https://doi.org/10.1007/s00005-021-00612-x" rel="noopener noreferrer">https://doi.org/10.1007/s00005-021-00612-x</a> - 2021

PubReading [290] - Placebo Controls- Now??? - A. Caplan

Researchers would love if they can expand time to fit in that publication, article, or review of their topic of interest; if that were true, however, there is no end to bottomless scrolling and missing the important details. PubReading would read out the abstract, results, and discussions to allow hassle-free information and a chance to create connections with like-minded individuals.

Share PubReading [290] - Placebo Controls- Now??? - A. Caplan

Sign up to save your podcasts

PubReading [290] - Placebo Controls- Now??? - A. Caplan

PubReading [290] - Placebo Controls- Now??? - A. Caplan